BioCentury
ARTICLE | Company News

API Co. Ltd., UMN Pharma, Yakult deal

March 11, 2013 7:00 AM UTC

Yakult, UMN and API signed a letter of intent to co-develop and commercialize biosimilars of several undisclosed antibodies for cancer. UMN and API will provide manufacturing and APIs, while Yakult wi...